advanced search
DEVELOPING EFFECTIVE TRAINING DEVICES FOR THE PULMONARY HEALTHCARE MARKET
PULMONARY
Joe Reynolds
Noble
DEVELOPING EFFECTIVE TRAINING DEVICES FOR THE PULMONARY HEALTHCARE MARKET
Pulmonary drug delivery is an effective route of pharmaceutical administration but research has shown that a large majority of patients fail to use their devices properly, training devices can help address this problem. Joe Reynolds looks at the design challenges that need to be addressed as well as some of the latest features that can be incorporated to develop optimal training devices for patients.
A NOVEL POWDER FILLING TECHNOLOGY TO REDUCE DEVELOPMENT COSTS & TIMELINES
PULMONARY
Simon Strothers
3P Innovation
A NOVEL POWDER FILLING TECHNOLOGY TO REDUCE DEVELOPMENT COSTS & TIMELINES
Simon Strothers and Dave Seaward discuss the evolution of filling technology in the inhaled world, including a new technology and approach to filling which offers significant advantages over conventional filling systems.
KEY CONSIDERATIONS FOR NON-CLINICAL SAFETY ASSESSMENT OF INHALED BIOPHARMACEUTICALS
EXPERT VIEW
Dr Simon Moore
KEY CONSIDERATIONS FOR NON-CLINICAL SAFETY ASSESSMENT OF INHALED BIOPHARMACEUTICALS
Simon Moore, Kirsty Haprer and Sylwia Marshall highlight some of the key considerations for the development of inhaled biopharmaceuticals, including non-clinical safety assessment.
A NEW VALUE PROPOSITION OF SMART DEVICES: ADVANCED MEDICATION ADHERENCE MONITORING IN CLINICAL TRIALS
PREFILLED SYRINGES
Dr Andreas Schneider
Ypsomed
A NEW VALUE PROPOSITION OF SMART DEVICES: ADVANCED MEDICATION ADHERENCE MONITORING IN CLINICAL TRIALS
Andreas Schneider explores a new value proposition of smart injection systems, introducing how advanced adherence monitoring services resolve some of the key challenges of clinical research practice regarding costs, adherence, data quality and integrity, Dr Schneider explains which technical features are needed for smart devices to provide value-adding adherence monitoring services, using SmartPilot for YpsoMate as a case study.
PRODUCT SHOWCASE: APTAR PHARMA’S PREMIUM PORTFOLIO
PREFILLED SYRINGES
Arnaud Fournier
Aptar Pharma
PRODUCT SHOWCASE: APTAR PHARMA’S PREMIUM PORTFOLIO
For over 50 years Aptar Pharma’s injectables specialists have led the way in developing innovative elastomer solutions. Their commitment to continuous improvement has resulted in elastomer formulations that feature best-in-class extractables and leachables profiles.
DEVELOPING DEMONSTRATORS TO INCREASE PATIENT CONFIDENCE & REDUCE ANXIETY
PREFILLED SYRINGES
Joe Reynolds
Noble
DEVELOPING DEMONSTRATORS TO INCREASE PATIENT CONFIDENCE & REDUCE ANXIETY
Using Noble’s recent partnership with BD to develop trainers for BD’s UltraSafe™ needle safety technology as an example, Joe Reynolds discusses the importance of training devices for the successful onboarding of patients beginning to use self-injected therapeutics, and how Noble’s training devices are designed to be faithful to the look and feel of the real product.
A REVIEW OF REUSABLE AUTO-INJECTORS FOR BIOLOGICAL & BIOSIMILAR DRUGS
PREFILLED SYRINGES
Dr Menachem Zucker
A REVIEW OF REUSABLE AUTO-INJECTORS FOR BIOLOGICAL & BIOSIMILAR DRUGS
From the perspective of the growing biologics and emerging biosimilars markets, Menachem Zucker showcases E3D – Elcam Drug Delivery Devices' mechanical and electronic auto-injector platforms, both of which are reusable devices with disposable cassettes.
DOES THE NEW EU MDR SPELL THE END OF GRANDFATHERING?
EXPERT VIEW
Helen Simmons
DOES THE NEW EU MDR SPELL THE END OF GRANDFATHERING?
Helen Simons and Stephanie Ward describe how the new EU Medical Devices Regulation will impact on “grandfathered” devices that were approved under old regulation and are currently on the market, but do not necessarily comply with current/updated regulatory standards, and explain the potential implications for device manufacturers.
THE VALUE OF A BD INTEGRATED SYSTEM FOR COMBINATION PRODUCTS
PREFILLED SYRINGES
Dr Theresa Bankston
BD (Becton Dickinson & Company)
THE VALUE OF A BD INTEGRATED SYSTEM FOR COMBINATION PRODUCTS
Theresa Bankston looks at the advantages of using an integrated system for drug-device combination products. As well as avoiding problems such as breakage and incompatibility, integrated products can offer solutions at every interface between the drug, container and delivery device and save significant amounts of time and money.
THE UNIVERSE OF PRE-FILLED SYRINGES & INJECTION DEVICES
CONFERENCE SHOWCASE
Dr Georg Roessling
PDA
THE UNIVERSE OF PRE-FILLED SYRINGES & INJECTION DEVICES
This year’s Universe of Pre-filled Syringes and Injection Devices will examine increasingly important issues, such as the new patient-centric business reality for the self-injection market and rising US FDA concerns about self-injection.
TORSTEN MASCHKE, DATWYLER SEALING SOLUTIONS
INTERVIEW
Torsten Maschke
TORSTEN MASCHKE, DATWYLER SEALING SOLUTIONS
Torsten Maschke has been Chief Executive of the Sealing Solutions division of Datwyler and a member of the group’s Executive Board since October 2016. Before joining Datwyler Group, he was responsible for the worldwide distribution of sealing and damping solutions for the automotive industry at Freudenberg Group (Weinheim, Germany).
UNISAFE<sup>®</sup>: THE IMPORTANCE OF ROBUST DESIGN PREDICTIONS IN DEVICE MANUFACTURING
PREFILLED SYRINGES
Damian Holland
Owen Mumford
UNISAFE®: THE IMPORTANCE OF ROBUST DESIGN PREDICTIONS IN DEVICE MANUFACTURING
Damian Holland outlines how the design team went about creating a safer and user-friendly springless safety syringe – UniSafe® – which bypasses some of the problems associated with spring-based devices.
PROFITABLE PACKAGING & MODULAR THINKING FOR INDUSTRY 4.0
PREFILLED SYRINGES
Christoph Hammer
PROFITABLE PACKAGING & MODULAR THINKING FOR INDUSTRY 4.0
Christoph Hammer discusses the financial reasoning behind the selection of packaging equipment, taking into account real current and potential future requirements (paying particular attention to Industry 4.0 concepts), and highlighting the advantages of taking a modular approach, such as the solutions offered by Dividella and its sister companies.
THE MAKINGS OF INNOVATION IN ADVANCED DRUG DELIVERY
PREFILLED SYRINGES
SHL Medical
THE MAKINGS OF INNOVATION IN ADVANCED DRUG DELIVERY
In the context of recent industry trends and market demands, including the emergence of biosimilars and increasingly viscous formulations, SHL provides an update on its portfolio of auto-injector products, including two new devices, Maggie® and Bertha™.
CRITICAL MATERIAL CONSIDERATIONS FOR DRUG CONTAINMENT
PREFILLED SYRINGES
Richard Molin
CRITICAL MATERIAL CONSIDERATIONS FOR DRUG CONTAINMENT
Dick Molin highlights some of the hazards that arise through the use of traditional lubricious coatings in parenteral delivery devices. Particular focus is paid to the problems of protein aggregation and trace impurities leaching from elastomeric components before describing how the polymer Parylene, applied as a very thin coating using SCS’ unique deposition method, avoids them.
NEWGUARD – PAVING THE WAY FOR A NEW SAFETY STANDARD
PREFILLED SYRINGES
Philippe Lesaulnier
Biocorp
NEWGUARD – PAVING THE WAY FOR A NEW SAFETY STANDARD
Needlestick injuries remain a serious concern for pharmaceutical companies involved in injectable drugs. Biocorp has been developing NewGuard™, an integrated passive safety device to tackle this problem. Throughout the development phase, Biocorp defined key elements to ensure NewGuard™ will not require unnecessary changes to be made to the PFS manufacturing process. Philippe Lesaulnier and Eric Dessertenne explain more.
STEVEN R KAUFMAN, BESPAK
INTERVIEW
Steven Kaufman
Bespak
STEVEN R KAUFMAN, BESPAK
Steven Kaufman is Global Business Development Lead at Bespak Europe Ltd, responsible for business development activities related to injectable devices such as auto-injectors and wearable injection systems.
USING POLYMERIC PDC TECHNOLOGY TO IMPROVE AUTO-INJECTOR DESIGN
PREFILLED SYRINGES
Jonathan Lawson
SMC Ltd
USING POLYMERIC PDC TECHNOLOGY TO IMPROVE AUTO-INJECTOR DESIGN
The limitations of using glass-based auto-injectors, such as contamination, and the need for delivering complex, viscous preparations, have led to a new approach that uses polymeric PDC technology instead. Jonathan Lawson, Jonathan Bradshaw and Susie White look at what polymeric PDCs can offer in making auto-injectors truly patient-centric.
DESIGN VALIDATION TESTING – DRUG DELIVERY DEVICES
EXPERT VIEW
Mark Turner
DESIGN VALIDATION TESTING – DRUG DELIVERY DEVICES
From a regulatory perspective, Mark Turner provides a summary of the current requirements of parenteral device manufacturers in the area of design validation testing.
COMPLEX DEVICES, SIMPLE PATIENT CARE
PREFILLED SYRINGES
Adrien Tisserand
Nemera
COMPLEX DEVICES, SIMPLE PATIENT CARE
Adrien Tisserand explains how the recent granting of German Pharmaceutical Drug Manufacturing Authorisation for Nemera’s facility in Neuenburg enhances the company’s offering to industry, before going on to discuss the Safelia® auto-injector and Safe’n’Sound® safety device platforms.
WEARABLE INJECTOR PLATFORM: THE CASE FOR EARLY PARTNERING
WEARABLES
Dr Jeannie Joughin
Enable Injections
WEARABLE INJECTOR PLATFORM: THE CASE FOR EARLY PARTNERING
Jeannie Joughin describes how significant factors and developments have converged leading to the rise of patient-centric healthcare and self-administration, the wearable injector at the cutting edge. Also showing that early clinical partnership with a platform wearable device company is beneficial across numerous criteria, and how this was a key design consideration for Enable’s wearable technology.
PUTTING PATIENTS FIRST: INNOVATING DRUG CONTAINMENT AND DELIVERY
WEARABLES
Chris Henshall
West Pharmaceutical Services
PUTTING PATIENTS FIRST: INNOVATING DRUG CONTAINMENT AND DELIVERY
Innovations in self-administered drug delivery systems are transitioning care out of hospitals and clinical settings into the home. To ensure patient compliance with treatment is maintained, an easy-to-use self-administration system can be key. Chris Henshall discusses the factors manufacturers should consider to ensure self-injected therapies meet patients’ needs and therefore improve patient outcomes.
HOW LUBRICANT CHOICE AFFECTS DOSE ACCURACY IN INSULIN PUMPS
WEARABLES
Dr Jackson Thornton
HOW LUBRICANT CHOICE AFFECTS DOSE ACCURACY IN INSULIN PUMPS
The development of fully automated, closed-loop glucose monitoring and insulin delivery systems can closely mimic a real pancreas. However, since the patient is not directly involved in administering the dose, these devices depend on one key factor - dosing accuracy. Jackson Thornton and Vinay Sakhrani examine how lubricant selection in the insulin cartridge, typically an afterthought, can make the delivery device more accurate.
DEVICE TRAINING AND ONBOARDING CONSIDERATIONS FOR ON-BODY DELIVERY SYSTEMS
WEARABLES
Joe Reynolds
Noble
DEVICE TRAINING AND ONBOARDING CONSIDERATIONS FOR ON-BODY DELIVERY SYSTEMS
New delivery systems for larger volume and more complex drugs, such as wearable injectors, are revolutionising patient treatment. However, research has shown that patients need to receive quality training and onboarding to ensure they use the devices properly and retain the information. Joe Reynolds explores the factors that need to be considered in developing optimal training devices for patients.

See what ondrugdelivery's readers and contributors think


Donna Bibber
President
Micro Engineering Solutions

I picked up your latest copy at the Boston PODD event and read it with great interest. You’ve really come a long way and you put out an amazingly professional and value-packed magazine.


Li-Chun Tsou, PhD, MBA
Principal Engineer
Merck & Co

Your website and publication is a great asset for me. I’d recommend your publication to my colleagues. I am sure that we will gain knowledge and update information through your timely report. Thanks for making it available.


Dr Cristian Vilos

I‘m working on the development of microparticles for the release of veterinary antibiotics, and polymeric nanoparticles for siRNA and chemotherapeutic delivery. ONdrugDelivery has been a very usefull platform to connect the scientific research, and marketed drug development.


Matt Kempton user photo
Matt Kempton
Snr Project Engineer
Corning Incorporated

I am extremely impressed with the comprehensive presentation of information and problem/solution points detailed ... Kudos to you for an extremely well written article with succinct and robust scientific body of knowledge.


Top